Implantable cardioverter-defibrillators (ICDs) significantly cut the rate of sudden cardiac death in patients with non-ischemic systolic heart failure, and reduced all-cause mortality in patients younger than 68 years. Results from the Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH) also highlighted the importance of targeting implantable ICD treatment to the patients with non-ischemic systolic heart failure who are most likely to benefit from it. The DANISH results “tell us ICDs can benefit patients if we can be a little better in selecting the right patients,” said Lars Køber, MD, professor of cardiology at the University of Copenhagen. Read more on which patients would benefit most from ICDs in this article from Cardiology News , available at: http://www.ecardiologynews.com/specialty-focus/heart-failure/single-article-page/video-icds-cut-mortality-in-younger-healthier-heart-failure-patients/8b26c497ed439d4bac87c4086f0f74f1.html#mytake
Patient Information
VIDEO: ICDs cut mortality in younger, healthier heart failure patients
